Research

Cellular

GLP-1 receptor agonists may modify aortic disorders through anti-inflammatory, antioxidant, and antiatherogenic properties.

GLP-1 RAs could be considered for patients with aortic disorders due to their beneficial properties.

StrongSupportsmedium confidence
In addition to metabolic effects, GLP-1 RAs have anti-inflammatory, antioxidant, and antiatherogenic properties.
Kanwardeep Singh et al. · Cardiology in Review · 2025

Why this rating

The claim is supported by large trials and preclinical evidence.

Source

Beyond Glycemic Control: Glucagon-Like Peptide-1 Receptor Agonists as Potential Modifiers of Aortic Disease

Kanwardeep Singh et al. · Cardiology in Review · 2025

DOI 10.1097/crd.0000000000001045

reviewCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →